Vaccination News

The simultaneous administration of adjuvant zoster and influenza vaccines posed no additional safety risks in older adults, results from a randomized study showed.

It's that time of year again, everyone rolling up their sleeves to get a flu shot. This throwback episode dives into the history of the struggles pinning down the causative agent of flu and the journey to the vaccine!

A CDC advisory committee on Wednesday recommended that adults aged 65 years or older and anyone who is at least moderately immunocompromised receive a second dose of COVID-19 vaccine this season.

Another monoclonal antibody for preventing respiratory syncytial virus disease in infants could enter the market as early as next year, based on the results of two studies presented at IDWeek, Merck said.

LOS ANGELES — Interim data from a phase 2 clinical trial of the Jynneos mpox vaccine showed that it is safe and generates an antibody response in adolescents that is similar to the response seen in adults, researchers reported.

Vaccination coverage among kindergarteners in the United States is still declining from pre-pandemic levels, and some states are reporting exemption rates of more than 5%, according to the latest CDC data.

The number of pertussis cases in the United States has quadrupled over the last 12 months, according to the CDC, raising questions as to what is behind the sudden, significant spike.

A combination of remdesivir plus dexamethasone significantly reduced the risk for death among people hospitalized with COVID-19 with baseline oxygen requirements compared with dexamethasone alone, according to a study.

The threat from bird flu remains low for the general public, the CDC reiterated last week in an update related to a human case in Missouri with no exposure to infected animals.

Vaccination reduced influenza-related hospitalizations by around one-third in the Southern Hemisphere this year, according to interim data published Thursday by the CDC.